LEN vs STAA · rev $34.19B vs rev $313.9M
LEN (LEN) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported STAA revenue for 2024-12-27 was $313.9M. Net income was -$20.2M. Revenue was down 2.6% from 2023-12-29 to 2024-12-27. STAA currently screens at market cap $1.45B.
LEN currently screens at market cap $0. STAA currently screens at market cap $1.45B.
Not investment advice. Open the LEN and STAA stock pages for the full models.
Not investment advice.